CVS Health’s (CVS) Dividend Outlook: Can the Retail-Pharma Giant Deliver in 2025?

CVS Health Corporation (NYSE:CVS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025.

CVS Health’s (CVS) Dividend Outlook: Can the Retail-Pharma Giant Deliver in 2025?

A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products.

CVS Health Corporation (NYSE:CVS)’s retail pharmacy business may be widely recognized, but it represents just a small portion of its broader business. The company also runs a top-tier pharmacy benefits management division and owns Aetna, a major player in the health insurance space.

Although CVS Health Corporation (NYSE:CVS)’s stock took a significant hit last year, it has rebounded this year. The stock has surged by over 43% since the start of 2025. The company also reported strong earnings in the first quarter of 2025, with revenues coming in at $94.6 billion. The revenue showed a 7% growth from the same period last year and also beat analysts’ estimates by $1.22 billion.

CVS Health Corporation (NYSE:CVS) also posted a solid cash position with an operating cash flow of $4.6 billion. The company increased its operating cash flow forecast from around $6.5 billion to roughly $7.0 billion. This cash position has enabled the company to pay uninterrupted dividends to shareholders since 1997. Currently, it offers a quarterly dividend of $0.665 per share and has a dividend yield of 4.20%, as of July 17.

READ NEXT: 13 Best Industrial Dividend Stocks to Buy Right Now and 10 Best Passive Income Stocks to Buy Now.

Disclosure: None.